Gli Transcriptional Activity Is Essential for Kras-Induced Pancreatic Tumorigenesis and Regulates IKBKE/NF-\(\kappa\)B Activity in the Tumor Epithelium

View/ Open
Author
Rajurkar, Mihir
de Jesus-Monge, Wilfredo E.
Driscoll, David R.
Appleman, Victoria A.
Huang, He
Cotton, Jennifer
Klimstra, David
Zhu, Lihua
Simin, Karl
Xu, Lan
Lewis, Brian
Mao, Junhao
Note: Order does not necessarily reflect citation order of authors.
Metadata
Show full item recordCitation
Rajurkar, Mihir, Wilfredo E. de Jesus-Monge, David R. Driscoll, Victoria A. Appleman, He Huang, Jennifer L. Cotton. Forthcoming. Gli transcriptional activity is essential for Kras-induced pancreatic tumorigenesis and regulates IKBKE/NF-\(\kappa\)B activity in the tumor epithelium. Proceedings of the National Academy of Science.Abstract
Pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive human malignances, is thought to be initiated by KRAS activation. Here we find that transcriptional activation mediated by the Gli family of transcription factors, although dispensable for pancreatic development, is required for Kras-induced proliferation and survival in primary pancreatic epithelial cells in culture, and Kras-driven pancreatic intraepithelial neoplasia and PDAC formation in vivo. Further, ectopic Gli1 activation in the mouse pancreas accelerates Kras-driven tumor formation, underscoring the importance of Gli transcription factors in pancreatic tumorigenesis. Interestingly, we demonstrate Gli-stimulated IKBKE (IKK\(\varepsilon\))/nuclear factor-\(\kappa\)B (NF-\(\kappa\)B) activity in pancreatic cancer cells in culture and in vivo, and show that this activity is a critical downstream mediator for Gli-dependent PDAC cell transformation and survival. Together, these studies demonstrate for the first time the requirement for Gli in Kras- dependent pancreatic epithelial transformation, implicate a novel mechanism of Gli-NF-\(\kappa\)B oncogenic activation, and provide genetic evidence supporting the therapeutic targeting of Gli activity in pancreatic cancer.Terms of Use
This article is made available under the terms and conditions applicable to Open Access Policy Articles, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#OAPCitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:8531456
Collections
- FAS Scholarly Articles [18179]
Contact administrator regarding this item (to report mistakes or request changes)